Artificial intelligence in rare neurological diseases: a scoping review of the evidence landscape and framework for foundation model integration

Egyptian Journal of Neurology, Psychiatry and Neurosurgery · Published 2026-07-29 · DOI 10.1186/s41983-026-01208-y

Free full text

Authors (2)

Shih-Shuan Fang, Shenghan Chen

Abstract

Background Rare neurological disorders, affecting approximately 30–40% of the estimated 400 million individuals with rare diseases worldwide, present fundamental challenges to artificial intelligence (AI) development due to limited patient cohorts, heterogeneous phenotypes, and fragmented data infrastructure. Whether recent advances in foundation models and large language models can overcome these “small-n” constraints remains an open question with profound implications for precision neurology. Results From 1847 records identified, 89 studies met inclusion criteria after screening. The evidence concentrates in five disease clusters: amyotrophic lateral sclerosis (ALS, 28%), Huntington disease (HD, 18%), myasthenia gravis (MG, 14%), muscular dystrophies (12%), and rare epilepsies (9%). Classical machine learning approaches (random forests, SVMs) predominate (51%), with deep learning (convolutional neural networks, recurrent neural networks) comprising 34%, and foundation model–based approaches representing an emerging but rapidly growing 15%. Neuroimaging is the most common data modality (47%), followed by genomic/multi-omic (26%) and clinical/electrophysiological data (27%). Only 24% of studies reported external validation, and among those, approximately one-third demonstrated clinically significant performance degradation. A parallel assessment of 156 international rare disease registries revealed that only 22% utilize internationally recognized Common Data Elements (CDEs), identifying semantic interoperability as the critical bottleneck for federated AI implementation.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Citation

Fang, S., Chen, S. (2026). Artificial intelligence in rare neurological diseases: a scoping review of the evidence landscape and framework for foundation model integration. Egyptian Journal of Neurology, Psychiatry and Neurosurgery. https://doi.org/10.1186/s41983-026-01208-y

Related articles